TC
LKFT

Tejara Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Tejara Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-53,786
Closed -$1.35M – 80
2025
Q1 		$1.35M Buy
+53,786
New +$1.36M 0.52% 46

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital's LKFT Position: Q2 2025 in Review

Tejara Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2025, closing a stake of 53,786 shares — an estimated $1.35M sold.

Tejara Capital first reported a position in LKFT in Q1 2025 and held it in 1 quarter. The position peaked at $1.35M in Q1 2025. 85 funds tracked by Wall St. Rank hold LKFT as of Q2 2025.

  • Tejara Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2025 after selling out during the quarter.
  • Tejara Capital sold 53,786 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2025, an estimated $1.35M.
  • Tejara Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2025 and held it in 1 quarter.
  • Tejara Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.35M in Q1 2025.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2025.

Based on Tejara Capital's 13F filing for Q2 2025, filed 13 Aug 2025.